A phase 1b trial of SENS-111 in severe bouts patients with vertigo
Phase of Trial: Phase I
Latest Information Update: 14 Dec 2016
At a glance
- Drugs SENS 111 (Primary)
- Indications Vertigo
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Sensorion
- 14 Dec 2016 According to a Sensorion media release, data will be presented at the 40th Association for Research in Otolaryngology (ARO) MidWinter Meeting 2017.
- 01 Sep 2016 According to Sensorion media release, results from this study will be presented at The European Association for Clinical Pharmacology and Therapeutics (EACPT).
- 12 May 2016 According to Sensorion media release, data will be presented at the American Academy of Otolaryngology-Head and Neck Surgery Foundation's 2016 Annual Meeting & OTO EXPO.